Biodexa Pharmaceuticals Plc (BDRX)
0.9828
+0.02
(+2.39%)
USD |
NASDAQ |
May 31, 16:00
0.9727
-0.01
(-1.03%)
Pre-Market: 20:00
Biodexa Pharmaceuticals Accounts Receivable (Quarterly): 0.00 for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| June 30, 2023 | 1.139M |
| June 30, 2023 | 1.139M |
| December 31, 2022 | 0.3982M |
| June 30, 2022 | 1.508M |
| June 30, 2022 | 1.508M |
| December 31, 2021 | 0.0445M |
| June 30, 2021 | 1.936M |
| June 30, 2021 | 1.936M |
| December 31, 2020 | 0.1295M |
| June 30, 2020 | 4.516M |
| June 30, 2020 | 4.516M |
| December 31, 2019 | 1.301M |
| June 30, 2019 | 1.114M |
| Date | Value |
|---|---|
| June 30, 2019 | 1.114M |
| December 31, 2018 | 0.1129M |
| June 30, 2018 | 0.94M |
| June 30, 2018 | 0.94M |
| December 31, 2017 | 3.016M |
| June 30, 2017 | 3.355M |
| June 30, 2017 | 3.355M |
| December 31, 2016 | 1.754M |
| June 30, 2016 | 2.023M |
| June 30, 2016 | 2.023M |
| December 31, 2015 | 1.459M |
| June 30, 2015 | 2.033M |
| June 30, 2015 | 2.033M |
| December 31, 2014 | 0.2942M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2023
4.516M
Maximum
Jun 2020
1.487M
Average
1.139M
Median
Jun 2023